Royalty Pharma plc (RPRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $33.81B, a trailing price-to-earnings ratio of 11.1 and a free-cash-flow yield of 7.5%. Over the most recent reported fiscal year, revenue grew 5.1% and free cash flow per share fell 5.3%.